Document Detail

The Safety and Efficacy of 12 Versus 24 Hours of Tirofiban Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention.
MedLine Citation:
PMID:  24737688     Owner:  NLM     Status:  Publisher    
Aim:We aimed to investigate the 6-month efficacy and safety of postprocedural 12-hour tirofiban administration versus 24-hour tirofiban administration in patients with ST-segment elevated myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI).Methods:This retrospective study enrolled 349 patients with STEMI who underwent primary PCI. Following the administration of bolus tirofiban after primary PCI, those receiving a 12-hour tirofiban infusion as the maintenance dose were classified as group 1 (n = 123) while those receiving a 24-hour infusion were classified as group 2 (n = 226). In-hospital and 6-month major adverse cardiac events were recorded.Results:There were no statistically significant differences between the 2 groups regarding in-hospital efficacy (in-hospital death: 4.4% vs 5.7%, P = .600 and stent thrombosis 1.8% vs 1.6%, P = .921) and in-hospital safety (2.6% vs 1.6% for major bleeding and 5.3% vs 4.1% for minor bleeding, P = .562). During the 6-month follow-up period, the incidence of the recurrent revascularization (16.1% vs 15.5%, odds ratio [OR] = 1.05 [0.47-3.67]), the repeated nonfatal acute coronary syndrome and/or stent thrombosis (27% vs 24.4%, P = .598, OR = 1.02 [0.42-2.48]), and the cardiovascular deaths (6.6% vs 6.5%, P = .943, OR = 1.03 [0.43-2.43]) were comparable between group 1 and group 2.Conclusion:Our study revealed that 12-hour tirofiban administration versus 24-hour tirofiban administration in STEMI who underwent primary PCI was similar with respect to in-hospital efficacy and safety and major adverse cardiac events during 6-month follow-up.
Selim Topcu; Huseyin Karal; Ahmet Kaya; Eftal Murat Bakirci; Ibrahim Halil Tanboga; Mustafa Kurt; Enbiya Aksakal; Mahmut Acikel; Serdar Sevimli
Related Documents :
19786888 - Intracardiac echocardiography and electroanatomic mapping in diagnosis of arrhythmogeni...
963848 - Use of changes in the epicardial qrs complex to assess interventions which modify the e...
1967558 - Lack of diurnal variation in the onset of non-q wave infarction.
10573488 - Can the surface electrocardiogram be used to predict myocardial viability?
21057968 - Thrombotic occlusion of the ascending aorta after toyobo lvad implantation with descend...
872308 - Follow-up technetium-99m stannous pyrophosphate myocardial scintigrams after acute myoc...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-4-14
Journal Detail:
Title:  Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis     Volume:  -     ISSN:  1938-2723     ISO Abbreviation:  Clin. Appl. Thromb. Hemost.     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-4-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9508125     Medline TA:  Clin Appl Thromb Hemost     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fluorescent Mimetics of CMP-Neu5Ac Are Highly Potent, Cell-Permeable Polarization Probes of Eukaryot...
Next Document:  Aqueous Self-Assembly and Cation Selectivity of Cobaltabisdicarbollide Dianionic Dumbbells.